Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Creates Subsidiary in the UK to Promote Business in Europe

NEW YORK, March 10 (GenomeWeb News) - Gene Logic has established a wholly-owned subsidiary of the same name in the UK, the company said today.

 

Starting this month, the new operation will help facilitate sales, marketing, and customer support in Europe. It has already hired an executive director for business development and will add additional personnel over the coming months.

 

Several European pharmaceutical companies are customers of Gene Logic, which is based in Gaithersburg, Md. "This new Gene Logic initiative enables us to forge a closer working relationship with this portion of our international customer base," said Gene Logic chairman and CEO Mark Gessler in a statement.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.